Description
Learn how buyers assess quality maturity, why reactive investments fail to create value, and how to build scalable, stage-appropriate quality systems that stand up to inspection and diligence scrutiny. Practical decision-making for what’s required before first-in-human, Phase 3, and commercialization — and why timing matters.
Speakers
- Ray Forslund, PhD (EVP, Product Development, Syner-G)
- Kelley Gillespie (Sr. Director, Quality and Compliance, Syner-G)
